Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applications of Genome-Editing Technologies for Type 1 Diabetes

26 Dec 2023

Abstract excerpt

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the destruction of insulin-producing pancreatic β-cells by the immune system. Although conventional therapeutic modalities, such as insulin injection, remain a mainstay, recent years have witnessed the emergence of novel treatment approaches encompassing immunomodulatory therapies, such as stem cell and β-cell transplantation, along with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Pancreatic function and diabetes
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38203514
DOI: 10.3390/ijms25010344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applications of Genome-Editing Technologies for Type 1 DiabetesPMID 38203514Read ↗

CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?Semantic proximity Read ↗

Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”Semantic proximity Read ↗

Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirectionSemantic proximity Read ↗

Gene therapy and type 1 diabetes mellitusSemantic proximity Read ↗

Novel Treatment Modalities of Type 1 Diabetes Mellitus: Opportunities and ChallengesSemantic proximity Read ↗

Emerging Gene Therapy Strategies for Type 1 Diabetes: A Review of Potential TreatmentsSemantic proximity Read ↗

New tools for experimental diabetes research: Cellular reprogramming and genome editing.Semantic proximity Read ↗

Gene therapy in diabetesSemantic proximity Read ↗

Type 1 diabetes.Semantic proximity Read ↗

CRISPR-Cas9 Therapeutics in Diabetes Mellitus: From Molecular Mechanisms and Pharmacology to Clinical Development and Translational BarriersSemantic proximity Read ↗

TRAJ23 Gene Targeting as a Therapeutic Strategy for Type 1 Diabetes: Implications from NOD Mouse Model StudiesSemantic proximity Read ↗

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.